These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27861357)

  • 1. The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.
    Ye Z; Lu H; Guo W; Dai W; Li H; Yang H; Li L
    Medicine (Baltimore); 2016 Nov; 95(46):e5306. PubMed ID: 27861357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.
    Xie J; Jiang M; Lin Y; Deng H; Li L
    Angiology; 2019 Aug; 70(7):594-612. PubMed ID: 30669852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis.
    Zhang JZ; Kang XJ; Gao Y; Zheng YY; Wu TT; Li L; Liu F; Yang YN; Li XM; Ma YT; Xie X
    Sci Rep; 2017 Apr; 7(1):1045. PubMed ID: 28432310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of contrast-induced nephropathy with prostaglandin E1 in patients undergoing percutaneous coronary procedures: A meta-analysis of 24 randomized controlled trials
.
    Liu X; Hang Y; Shen L; Yang J; Zhou L; Sha W; Lu G
    Clin Nephrol; 2018 Nov; 90(5):313-324. PubMed ID: 30106366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.
    Li WH; Li DY; Qian WH; Liu JL; Xu TD; Zhu H; He HY
    Int Urol Nephrol; 2014 Apr; 46(4):781-6. PubMed ID: 24570327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    Medicine (Baltimore); 2017 Mar; 96(9):e6059. PubMed ID: 28248861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Alprostadil in Preventing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis.
    Xu H; Wang H; Zhang C; Xiao J; Hua N; Tang X; Xie J; Zhang Z
    Angiology; 2021 Oct; 72(9):878-888. PubMed ID: 33853365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xuebijing injection combined with alprostadil in the treatment of diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Hao N; Liu Y; Guo L; Li W; Zhao P
    Medicine (Baltimore); 2024 Jun; 103(24):e32095. PubMed ID: 38875385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis on allopurinol preventive intervention on contrast-induced acute kidney injury with random controlled trials: PRISMA.
    Ma G; Wang G; Xiao D; Teng W; Hui X; Ma G
    Medicine (Baltimore); 2019 Jun; 98(25):e15962. PubMed ID: 31232927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis.
    He H; Chen XR; Chen YQ; Niu TS; Liao YM
    J Interv Cardiol; 2019; 2019():2750173. PubMed ID: 31772520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing contrast-induced acute kidney injury with probucol and hydration in patients with coronary heart disease: A systematic review and meta-analysis of randomized controlled trials.
    Cui X; Xie B; Wang H; Liu F; Mei L; Qin F; Zhang J; Yi X
    Medicine (Baltimore); 2023 Mar; 102(11):e33273. PubMed ID: 36930109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprostadil plays a protective role in contrast-induced nephropathy in the elderly.
    Miao Y; Zhong Y; Yan H; Li W; Wang BY; Jin J
    Int Urol Nephrol; 2013 Aug; 45(4):1179-85. PubMed ID: 23860961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
    Zhan B; Huang X; Jiang L; Bao H; Cheng X
    Angiology; 2018 Aug; 69(7):568-573. PubMed ID: 28950711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Yang SC; Fu NK; Zhang J; Liang M; Cong HL; Lin WH; Tian FS; Lu CZ; Sun TT; Zhang WY; Ma ZH
    Angiology; 2018 May; 69(5):393-399. PubMed ID: 29073785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis on efficacy of salvianolate in prevention of contrast-induced nephropathy].
    Xi YT; Yuan LY; Xu ST; Liu XY; Wu W
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2616-2626. PubMed ID: 31359732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.
    Wang J; Ai X; Li L; Gao Y; Sun N; Li C; Sun W
    Int Urol Nephrol; 2017 Nov; 49(11):2019-2026. PubMed ID: 28656510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
    Liang M; Yang S; Fu N
    Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Preventive Effect of Alprostadil on the Contrast-Induced Nephropathy of Coronary Heart Disease Treated by Percutaneous Coronary Intervention in Moderate and High-Risk Population Stratified by Mehran Score.
    Liu X; Zhang P; Zhang J; Zhang X; Yang S; Fu N
    Angiology; 2022 Jan; 73(1):33-41. PubMed ID: 34098771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.